(SOURCE: NIH/NATIONAL CANCER INSTITUTE) – Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified novel genomic and molecular characteristics of cervical cancer that will aid in the subclassification of the disease and may help target therapies that are most appropriate for each patient. The new study, a comprehensive analysis of the genomes of 178 […]
(SOURCE: UNIVERSITY OF SOUTH CAROLINA) – A team of University of South Carolina scientists led by Carolyn Banister and Phillip Buckhaults has identified a new subtype of cervical cancer that, like most cervical cancers, is triggered by human papillomavirus (HPV) but whose growth is not directed by the virus, suggesting that therapy targeting these tumors’ distinct genomic […]
(JOHNS HOPKINS MEDICINE) According to a recent press release, Johns Hopkins Medicine specialists report they have developed a urine test for the likely emergence of cervical cancer that is highly accurate compared to other tests based on genetic markers derived directly from cervical tissue.
(HARVARD T.H. CHAN SCHOOL OF PUBLIC HEALTH) According to a recent press release, women may only need cervical cancer screening every 5-10 years–instead of every three years, as currently recommended–and may be able to start the screenings later in life, according to a new study from Harvard T.H. Chan School of Public Health.
(UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS) According to a recent press release, standard-of-care treatment for locally advanced cervical cancer includes radiation, chemotherapy and brachytherapy (in which radiation is implanted internally). A University of Colorado Cancer Center study published in the journal Gynecologic Oncology shows that only 44 percent of patients in a large, national sample […]
(News Medical Life Sciences) According to a recent article published in New Medical Life Sciences, Researchers from the University of Otago in New Zealand have gained some new knowledge into how one of the main viruses that cause cervical cancer evades detection from immune systems.
(HealthDay News) According to a recent article in HealthDay News, the vaccine that protects against human papillomavirus (HPV) infection appears to be even more effective than previously thought, according to a report published online Sept. 29 in JAMA Oncology.